Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1070-2025Class I

Intact Vascular Tack Endovascular System, to treat vascular dissections with Tack implant(s) following...

Spectranetics Corp. / initiated 2025-01-10 / Open, Classified / root cause: design

Spectranetics Corporation began a recall of Intact Vascular Tack Endovascular System, to treat vascular dissections with Tack implant(s) following angioplasty: (4F,1.5-4.5mm), 150cm, REF: 154150041... on . FDA classified it as Class I and gives the reason as "Use of Tack Endovascular system, designed to treat acute dissections of inner wall or lining of an artery by tacking damaged tissue to inner luminal surface, could result in problems with deployment and stability of...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-1070-2025
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Spectranetics Corp.
Product
Intact Vascular Tack Endovascular System, to treat vascular dissections with Tack implant(s) following angioplasty: (4F,1.5-4.5mm), 150cm, REF: 154150041; Tack, 4F Gen 1.5, 150cm CE, REF: 154150042; Tack, 4F Gen 1.5, 90cm CE, REF: 154090042 (6F, 3.5 - 6.0mm), 135cm, REF: 156135061; (6F, 4.0 - 8.0mm), 135cm, REF: 206135061; Tack, 6F Gen 2.0, 135cm CE, REF: 206135062; Tack, 6F Gen 1.5, 135cm CE, REF: 156135062; Tack, 6F Gen 2.0, 80cm CE, REF: 206080062; Tack, 6F Gen 1.5, 80cm CE, REF: 156080062
Product code
QCT Scaffold, Dissection Repair
Reason for recall
Use of Tack Endovascular system, designed to treat acute dissections of inner wall or lining of an artery by tacking damaged tissue to inner luminal surface, could result in problems with deployment and stability of device in vessel after deployment, which may cause failure to resolve dissection, migration of implant, bailout stenting, reintervention, unintended removal of tack devices, and ischemia.
Root cause tag
design
FDA root cause
Device Design
Action
On 1/10/2025, Philips mailed recall notices to customers informing them of the following: Firm will no longer distributed the device. Check your product inventory and quarantine any affected devices to prevent use. Do not open or use any products that have been identified within your inventory. Circulate this notice to all users of the device, or to any organization where the affected product may have been transferred, so they are aware of the product Recall. Complete and return the response form via email to [email protected]
Quantity in commerce
2,939
Distribution
Distribution US nationwide and countries of: NL, DE, NL, AU, IT, CH, GB, and AT
Product codes and lots
UDI-DI: REF/UDI-DI/Batch: 154150041/00863328000189/332905 - 349049, 154150042/328641, REF: 154090042/322101, 156135061/00863328000103/332824 - 336121, 206135061/00850003494043/331281 - 336152, 206135062/328643 - 345567, 156135062/271330 - 283066, 206080062/321083 - 349035, 156080062/302251 - 349034

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1070-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1070-2025Class IOngoingVoluntary: Firm initiated